Wednesday, July 8, 2026

Drug profile · INN

magnesium sulfate anhydrous

magnesium sulfate anhydrous (MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — magnesium sulfate anhydrous
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

magnesium sulfate anhydrous (MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN magnesium sulfate anhydrous
Brand MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE
Mechanism Unknown
Route ORAL
Formulation SOLUTION

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. PRODIGE 51 - GASTFOX Phase 3 · CERo Therapeutics · Locally advanced or metastatic oesogastric adenocarcinoma

Frequently asked questions

What is magnesium sulfate anhydrous?

magnesium sulfate anhydrous (MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for magnesium sulfate anhydrous?

MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE is a marketed brand name for magnesium sulfate anhydrous. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of magnesium sulfate anhydrous?

magnesium sulfate anhydrous has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.